Bluejay Diagnostics Inc (BJDX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2020 | 12-2019 | 12-2017 | 12-2006 | |
| Cash Flows From Operating Activities | ||||
| Net Income | -1,158 | -820 | N/A | N/A |
| Depreciation Amortization | 157 | 143 | N/A | N/A |
| Accounts receivable | 1 | -1 | N/A | N/A |
| Accounts payable and accrued liabilities | 346 | -25 | N/A | N/A |
| Other Working Capital | 596 | -178 | N/A | N/A |
| Other Operating Activity | -450 | -809 | 0 | 0 |
| Operating Cash Flow | $-509 | $-1,690 | $N/A | $N/A |
| Cash Flows From Investing Activities | ||||
| PPE Investments | N/A | -6 | N/A | N/A |
| Investing Cash Flow | $N/A | $-6 | $N/A | $N/A |
| Cash Flows From Financing Activities | ||||
| Change In Short Term Borrowing | 270 | N/A | N/A | N/A |
| Other Financing Activity | 1,055 | 1,512 | 0 | 0 |
| Financing Cash Flow | $1,325 | $1,512 | $N/A | $N/A |
| Beginning Cash Position | 96 | 280 | N/A | N/A |
| End Cash Position | 912 | 96 | N/A | N/A |
| Net Cash Flow | $816 | $-184 | $N/A | $N/A |
| Free Cash Flow | ||||
| Operating Cash Flow | -509 | -1,690 | N/A | N/A |
| Capital Expenditure | N/A | -6 | N/A | N/A |
| Free Cash Flow | -509 | -1,696 | 0 | 0 |